The analysis of AZGP1 expression in malignant prostate epithelium in prostatectomy specimens from 228 prostate cancer patients revealed that absent or weak AZGP1 expression was associated with clinical recurrence, including localized recurrence, metastasis, or death. This evidence concerns the gene AZGP1 and prostate cancer.